Fountain Medical Development Limited (“FMD”) is a global Contract Research Organization (CRO) that is able to provide Clinical Development services of the ICH standards, and is engaged in delivery of high-quality and one-stop services in Clinical Research to Pharmaceuticals and Medical Device companies from abroad and China, including Regulatory Affairs, Medical Affairs, Clinical Operations, Data Management, Biostatistics, Pharmacovigilance and third-party audits. FMD is the first CRO that can provide joint drug development services in China and simultaneously in the US, Europe, Japan, Australia and Taiwan。

Since its foundation in 2007, FMD has established branches and offices in major cities of China, including Tianjin, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu, Shenyang, Shijiazhuang, Hong Kong and Taiwan, and foreign countries and regions, including US, UK, Armenia, Japan, South Korea, India and the Philippines, with more than 1,700 employees all over the world, among which, the growing clinical operation teams have spread their services to 55 cities in mainland China。

We are prepared to assist you in any way we can!

Want to learn more about FMD, or offer any suggestions, please contact one of our business development representatives? Just click here and let us know how we can help。

Featured Content

【学术分享】2018年影响中国制药行业注册申报的重要政策节选

2018年国家药品监督管理局继续延伸自2015年44号令以来鼓励创新和新药临床急需药品可及性的制度改革,加速审评审批,落实出台了对行业影响深远的相关政策。方恩医药将持续关注法规政策改革,为业界提供专业的咨询服务。

More

国际临床试验项目经验

迄今为止,方恩已参与并承担了超过 85 个创新药和近 20 个生物类似物的注册申报、临床设计和开发工作,涉及肿瘤、中枢系统、肝炎、艾滋病、哮喘、糖尿病,皮肤科等领域。

More

Latest News & Views

Blogs